Publications - Neill R. Graff-Radford, M.D.

Back to research profile

  1. Cannon A, Fujioka S, Rutherford NJ, Ferman TJ, Broderick DF, Boylan KB, Graff-Radford NR, Uitti RJ, Rademakers R, Wszolek ZK, Dickson DW. Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis. Neurology. 2013 May 7; 80(19):1771-7. Epub 2013 Apr 17.
    View PubMed
  2. van Blitterswijk M, Baker MC, Bieniek KF, Knopman DS, Josephs KA, Boeve B, Caselli R, Wszolek ZK, Petersen R, Graff-Radford NR, Boylan KB, Dickson DW, Rademakers R. Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia. Amyotroph Lateral Scler Frontotemporal Degener. 2013 May 02. [Epub ahead of print]
    View PubMed
  3. Pedraza O, Allen M, Jennette K, Carrasquillo M, Crook J, Serie D, Pankratz VS, Palusak R, Nguyen T, Malphrus K, Ma L, Bisceglio G, Roberts RO, Lucas JA, Ivnik RJ, Smith GE, Graff-Radford NR, Petersen RC, Younkin SG, Ertekin-Taner N. Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects. Alzheimers Dement. 2013 May 02. [Epub ahead of print]
    View PubMed
  4. Graff-Radford NR, Knopman DS, Penman AD, Coker LH, Mosley TH. Do systolic BP and pulse pressure relate to ventricular enlargement? Eur J Neurol. 2013 Apr; 20(4):720-4. Epub 2013 Jan 07.
    View PubMed
  5. Nicholson AM, Baker MC, Finch NA, Rutherford NJ, Wider C, Graff-Radford NR, Nelson PT, Clark HB, Wszolek ZK, Dickson DW, Knopman DS, Rademakers R. CSF1R mutations link POLD and HDLS as a single disease entity. Neurology. 2013 Mar 12; 80(11):1033-40. Epub 2013 Feb 13.
    View PubMed
  6. Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, Ahlskog JE, Caselli RJ, Jacobson S, Sabbagh M, Adler C, Woodruff B, Beach TG, Iranzo A, Gelpi E, Santamaria J, Tolosa E, Singer C, Mash DC, Luca C, Arnulf I, Duyckaerts C, Schenck CH, Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013 Mar 06. [Epub ahead of print]
    View PubMed
  7. Rayaprolu S, Fujioka S, Traynor S, Soto-Ortolaza AI, Petrucelli L, Dickson DW, Rademakers R, Boylan KB, Graff-Radford NR, Uitti RJ, Wszolek ZK, Ross OA. TARDBP mutations in Parkinson's disease. Parkinsonism Relat Disord. 2013 Mar; 19(3):312-5. Epub 2012 Dec 08.
    View PubMed
  8. Dejesus-Hernandez M, Rayaprolu S, Soto-Ortolaza AI, Rutherford NJ, Heckman MG, Traynor S, Strongosky A, Graff-Radford N, Van Gerpen J, Uitti RJ, Shih JJ, Lin SC, Wszolek ZK, Rademakers R, Ross OA. Analysis of the C9orf72 repeat in Parkinson's disease, essential tremor and restless legs syndrome. Parkinsonism Relat Disord. 2013 Feb; 19(2):198-201. Epub 2012 Oct 18.
    View PubMed
  9. Ferman TJ, Arvanitakis Z, Fujishiro H, Duara R, Parfitt F, Purdy M, Waters C, Barker W, Graff-Radford NR, Dickson DW. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease. Parkinsonism Relat Disord. 2013 Feb; 19(2):227-31. Epub 2012 Nov 20.
    View PubMed
  10. Josephs KA, Whitwell JL, Murray ME, Parisi JE, Graff-Radford NR, Knopman DS, Boeve BF, Senjem ML, Rademakers R, Jack CR Jr, Petersen RC, Dickson DW. Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia. Brain. 2013 Feb; 136(Pt 2):455-70. Epub 2013 Jan 28.
    View PubMed
  11. Pao WC, Boeve BF, Ferman TJ, Lin SC, Smith GE, Knopman DS, Graff-Radford NR, Petersen RC, Parisi JE, Dickson DW, Silber MH. Polysomnographic findings in dementia with Lewy bodies. Neurologist. 2013 Jan; 19(1):1-6.
    View PubMed
  12. Tan WW, Heckman MG, Vishnu P, Crook JE, Younkin LH, Covil EG, Ferman TJ, Graff-Radford NR, Younkin SG, Smallridge RC, Wehle MJ, Buskirk SJ. Effect of leuprolide on serum amyloid-beta peptide levels and memory in patients with prostate cancer with biochemical recurrence. Urology. 2013 Jan; 81(1):150-4.
    View PubMed
  13. Lu PH, Mendez MF, Lee GJ, Leow AD, Lee HW, Shapira J, Jimenez E, Boeve BB, Caselli RJ, Graff-Radford NR, Jack CR, Kramer JH, Miller BL, Bartzokis G, Thompson PM, Knopman DS. Patterns of brain atrophy in clinical variants of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2013; 35(1-2):34-50. Epub 2013 Jan 09.
    View PubMed
  14. Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, Valladares O, Lin CF, Larson EB, Graff-Radford NR, Evans D, De Jager PL, Crane PK, Buxbaum JD, Murrell JR, Raj T, Ertekin-Taner N, Logue M, Baldwin CT, Green RC, Barnes LL, Cantwell LB, Fallin Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein e epsilon 4, and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013; 309(14):1483-92.
  15. Rutherford NJ, Heckman MG, Dejesus-Hernandez M, Baker MC, Soto-Ortolaza AI, Rayaprolu S, Stewart H, Finger E, Volkening K, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Knopman DS, Kretzschmar HA, Neumann M, Caselli RJ, White CL Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging. 2012 Dec; 33(12):2950.e5-7. Epub 2012 Jul 26.
    View PubMed
  16. Janocko NJ, Brodersen KA, Soto-Ortolaza AI, Ross OA, Liesinger AM, Duara R, Graff-Radford NR, Dickson DW, Murray ME. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol. 2012 Nov; 124(5):681-92. Epub 2012 Sep 12.
    View PubMed
  17. Domoto-Reilly K, Sapolsky D, Brickhouse M, Dickerson BC, Alzheimer's Disease Neuroimaging Initiative. Naming impairment in Alzheimer's disease is associated with left anterior temporal lobe atrophy. Neuroimage. 2012 Oct 15; 63(1):348-55. Epub 2012 Jun 21.
    View PubMed
  18. Heggeli KA, Crook J, Thomas C, Graff-Radford N. Maternal transmission of Alzheimer disease. Alzheimer Dis Assoc Disord. 2012 Oct-Dec; 26(4):364-6.
    View PubMed
  19. Lo RY, Jagust WJ, Alzheimer's Disease Neuroimaging Initiative. Vascular burden and Alzheimer disease pathologic progression. Neurology. 2012 Sep 25; 79(13):1349-55. Epub 2012 Sep 12.
    View PubMed
  20. Rutherford NJ, Carrasquillo MM, Li M, Bisceglio G, Menke J, Josephs KA, Parisi JE, Petersen RC, Graff-Radford NR, Younkin SG, Dickson DW, Rademakers R. TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease. Neurology. 2012 Aug 14; 79(7):717-8. Epub 2012 Aug 01.
    View PubMed
  21. Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, Cotman CW, Decarli CS, Levey AI, Ringman JM, Mendez MF, Chui HC, Le Ber I, Brice A, Lupton Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet. 2012 Aug 1; 21(15):3500-12. Epub 2012 May 03.
    View PubMed
  22. Hamilton G, Killick R, Genetic and Environmental Risk for Alzheimer's Disease Consortium, Translational Genomics Research Institute Consortium, Lambert JC, Amouyel P, European Alzheimer Disease Initiative, Carrasquillo MM, Pankratz VS, Graff-Radford NR, Functional and genetic analysis of haplotypic sequence variation at the nicastrin genomic locus. Neurobiol Aging. 2012 Aug; 33(8):1848.e1-13. Epub 2012 Mar 08.
    View PubMed
  23. Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R, Grundman M, Liu E, AAB-001 201/202 Investigators. Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. Arch Neurol. 2012 Aug; 69(8):1002-10.
    View PubMed
  24. Ewers M, Schmitz S, Hansson O, Walsh C, Fitzpatrick A, Bennett D, Minthon L, Trojanowski JQ, Shaw LM, Faluyi YO, Vellas B, Dubois B, Blennow K, Buerger K, Teipel SJ, Weiner M, Hampel H, Alzheimer's Disease Neuroimaging Initiative. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging. 2012 Aug; 33(8):1599-608. Epub 2011 Jun 17.
    View PubMed
  25. Boeve BF, Graff-Radford NR. Cognitive and behavioral features of c9FTD/ALS. Alzheimers Res Ther. 2012 Jul 20; 4(4):29. [Epub ahead of print]
    View PubMed
  26. Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN, Nair AA, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus KG, Palusak R, Lincoln S, Bisceglio G, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Haines JL, Mayeux Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012 Jul 17; 79(3):221-8. Epub 2012 Jun 20.
    View PubMed
  27. Yuan L, Wang Y, Thompson PM, Narayan VA, Ye J, Alzheimer's Disease Neuroimaging Initiative. Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data. Neuroimage. 2012 Jul 2; 61(3):622-32. Epub 2012 Mar 29.
    View PubMed
  28. Bonner-Jackson A, Okonkwo O, Tremont G, Alzheimer's Disease Neuroimaging Initiative. Apolipoprotein E epsilon2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry. 2012 Jul; 20(7):584-93.
    View PubMed
  29. Wang H, Nie F, Huang H, Risacher SL, Saykin AJ, Shen L, Alzheimer's Disease Neuroimaging Initiative. Identifying disease sensitive and quantitative trait-relevant biomarkers from multidimensional heterogeneous imaging genetics data via sparse multimodal multitask learning. Bioinformatics. 2012 Jun 15; 28(12):i127-36.
    View PubMed
  30. Damoiseaux JS, Seeley WW, Zhou J, Shirer WR, Coppola G, Karydas A, Rosen HJ, Miller BL, Kramer JH, Greicius MD, Alzheimer's Disease Neuroimaging Initiative. Gender modulates the APOE epsilon4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. J Neurosci. 2012 Jun 13; 32(24):8254-62.
    View PubMed
  31. Desikan RS, McEvoy LK, Thompson WK, Holland D, Brewer JB, Aisen PS, Sperling RA, Dale AM, Alzheimer's Disease Neuroimaging Initiative. Amyloid-beta--associated clinical decline occurs only in the presence of elevated P-tau. Arch Neurol. 2012 Jun; 69(6):709-13.
    View PubMed
  32. Barral S, Bird T, Goate A, Farlow MR, Diaz-Arrastia R, Bennett DA, Graff-Radford N, Boeve BF, Sweet RA, Stern Y, Wilson RS, Foroud T, Ott J, Mayeux R, National Institute on Aging Late-Onset Alzheimer's Disease Genetics Study. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory. Neurology. 2012 May 8; 78(19):1464-71. Epub 2012 Apr 25.
    View PubMed
  33. Lo RY, Jagust WJ, Alzheimer's Disease Neuroimaging Initiative. Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology. 2012 May 1; 78(18):1376-82. Epub 2012 Apr 04.
    View PubMed
  34. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann O, Bernard M, Brown AA, Cannon DM, Chakravarty MM, Christoforou A, Domin M, Grimm O, Hollinshead M, Holmes AJ, Homuth G, Hottenga JJ, Langan C, Lopez Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet. 2012 May; 44(5):552-61. Epub 2012 Apr 15.
    View PubMed
  35. Glueckauf RL, Davis WS, Willis F, Sharma D, Gustafson DJ, Hayes J, Stutzman M, Proctor J, Kazmer MM, Murray L, Shipman J, McIntyre V, Wesley L, Schettini G, Xu J, Parfitt F, Graff-Radford N, Baxter C, Burnett K, Noel LT, Haire K, Springer J. Telephone-based, cognitive-behavioral therapy for African American dementia caregivers with depression: initial findings. Rehabil Psychol. 2012 May; 57(2):124-39.
    View PubMed
  36. Wider C, Ross OA, Nishioka K, Heckman MG, Vilarino-Guell C, Jasinska-Myga B, Erketin-Taner N, Rademakers R, Graff-Radford NR, Mash DC, Papapetropoulos S, Duara R, Uchikado H, Wszolek ZK, Farrer MJ, Dickson DW. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology. J Neurol Neurosurg Psychiatry. 2012 Apr; 83(4):424-9. Epub 2012 Jan 30.
    View PubMed
  37. Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 6; 109(10):3985-90. Epub 2012 Feb 16.
    View PubMed
  38. Chu C, Hsu AL, Chou KH, Bandettini P, Lin C, Alzheimer's Disease Neuroimaging Initiative. Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images. Neuroimage. 2012 Mar; 60(1):59-70. Epub 2011 Dec 01.
    View PubMed
  39. Rasmussen JM, Lakatos A, van Erp TG, Kruggel F, Keator DB, Fallon JT, Macciardi F, Potkin SG, Alzheimer's Disease Neuroimaging Initiative. Empirical derivation of the reference region for computing diagnostic sensitive (1)(8)fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample. Biochim Biophys Acta. 2012 Mar; 1822(3):457-66. Epub 2011 Sep 19.
    View PubMed
  40. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012 Mar; 135(Pt 3):765-83.
    View PubMed
  41. Sachs BC, Lucas JA, Smith GE, Ivnik RJ, Petersen RC, Graff-Radford NR, Pedraza O. Reliable change on the Boston naming test. J Int Neuropsychol Soc. 2012 Mar; 18(2):375-8. Epub 2012 Jan 23.
    View PubMed
  42. Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2012 Feb; 44(2):200-5. Epub 2011 Dec 25.
    View PubMed
  43. Pedraza O, Clark JH, O'Bryant SE, Smith GE, Ivnik RJ, Graff-Radford NR, Willis FB, Petersen RC, Lucas JA. Diagnostic validity of age and education corrections for the Mini-Mental State Examination in older African Americans. J Am Geriatr Soc. 2012 Feb; 60(2):328-31. Epub 2011 Dec 08.
    View PubMed
  44. Rutherford NJ, Finch NA, DeJesus-Hernandez M, Crook RJ, Lomen-Hoerth C, Wszolek ZK, Uitti RJ, Graff-Radford NR, Rademakers R. Pathogenicity of exonic indels in fused in sarcoma in amyotrophic lateral sclerosis. Neurobiol Aging. 2012 Feb; 33(2):424.e23-4. Epub 2010 Nov 12.
    View PubMed
  45. Dickerson BC, Wolk DA, Alzheimer's Disease Neuroimaging Initiative. MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology. 2012 Jan 10; 78(2):84-90. Epub 2011 Dec 21.
    View PubMed
  46. Mattila J, Koikkalainen J, Virkki A, van Gils M, Lotjonen J, Alzheimer's Disease Neuroimaging Initiative. Design and application of a generic clinical decision support system for multiscale data. IEEE Trans Biomed Eng. 2012 Jan; 59(1):234-40. Epub 2011 Oct 10.
    View PubMed
  47. Allen M, Cox C, Belbin O, Ma L, Bisceglio GD, Wilcox SL, Howell CC, Hunter TA, Culley O, Walker LP, Carrasquillo MM, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG, Ertekin-Taner N. Association and heterogeneity at the GAPDH locus in Alzheimer's disease. Neurobiol Aging. 2012 Jan; 33(1):203.e25-33. Epub 2010 Sep 23.
    View PubMed
  48. Wojtas A, Heggeli KA, Finch N, Baker M, Dejesus-Hernandez M, Younkin SG, Dickson DW, Graff-Radford NR, Rademakers R. C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. Am J Neurodegener Dis. 2012; 1(1):107-18. Epub 2012 May 16.
    View PubMed
  49. Zou F, Chai HS, Younkin CS, Allen M, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN, Nair AA, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus KG, Palusak R, Lincoln S, Bisceglio G, Georgescu C, Kouri N, Kolbert CP, Jen J, Haines JL, Mayeux R, Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet. 2012; 8(6):e1002707. Epub 2012 Jun 07.
    View PubMed
  50. Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS, Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Sando Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol Neurodegener. 2012; 7:13. Epub 2012 Apr 11.
    View PubMed
  51. Cruchaga C, Haller G, Chakraverty S, Mayo K, Vallania FL, Mitra RD, Faber K, Williamson J, Bird T, Diaz-Arrastia R, Foroud TM, Boeve BF, Graff-Radford NR, St Jean P, Lawson M, Ehm MG, Mayeux R, Goate AM, NIA-LOAD/NCRAD Family Study Consortium. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One. 2012; 7(2):e31039. Epub 2012 Feb 1.
    View PubMed
  52. Heckman MG, Soto-Ortolaza AI, Diehl NN, Carrasquillo MM, Uitti RJ, Wszolek ZK, Graff-Radford NR, Ross OA. Evaluation of the role of SNCA variants in survival without neurological disease. PLoS One. 2012; 7(8):e42877. Epub 2012 Aug 13.
    View PubMed
  53. Johnstone D, Milward EA, Berretta R, Moscato P, Alzheimer's Disease Neuroimaging Initiative. Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset. PLoS One. 2012; 7(4):e34341. Epub 2012 Apr 02.
    View PubMed
  54. Smith CD, Andersen AH, Gold BT, Alzheimer's Disease Neuroimaging Initiative. Structural brain alterations before mild cognitive impairment in ADNI: validation of volume loss in a predefined antero-temporal region. J Alzheimers Dis. 2012; 31 Suppl 3:S49-58.
    View PubMed
  55. Koikkalainen J, Polonen H, Mattila J, van Gils M, Soininen H, Lotjonen J, Alzheimer's Disease Neuroimaging Initiative. Improved classification of Alzheimer's disease data via removal of nuisance variability. PLoS One. 2012; 7(2):e31112. Epub 2012 Feb 13.
    View PubMed
  56. Silver M, Montana G, Alzheimer's Disease Neuroimaging Initiative. Fast identification of biological pathways associated with a quantitative trait using group lasso with overlaps. Stat Appl Genet Mol Biol. 2012; 11(1):Article 7. Epub 2012 Jan 06.
    View PubMed
  57. Holland D, Desikan RS, Dale AM, McEvoy LK, Alzheimer's Disease Neuroimaging Initiative. Rates of decline in Alzheimer disease decrease with age. PLoS One. 2012; 7(8):e42325. Epub 2012 Aug 02.
    View PubMed
  58. Whitcomb DC, LaRusch J, Krasinskas AM, Klei L, Smith JP, Brand RE, Neoptolemos JP, Lerch MM, Tector M, Sandhu BS, Guda NM, Orlichenko L, Alkaade S, Amann ST, Anderson MA, Baillie J, Banks PA, Conwell D, Cote GA, Cotton PB, DiSario J, Farrer LA, Forsmark Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet. 2012; 44(12):1349-54.
  59. Casanova R, Hsu FC, Espeland MA, Alzheimer's Disease Neuroimaging Initiative. Classification of structural MRI images in Alzheimer's disease from the perspective of ill-posed problems. PLoS One. 2012; 7(10):e44877. Epub 2012 Oct 10.
    View PubMed
  60. Kiddle SJ, Thambisetty M, Simmons A, Riddoch-Contreras J, Hye A, Westman E, Pike I, Ward M, Johnston C, Lupton MK, Lunnon K, Soininen H, Kloszewska I, Tsolaki M, Vellas B, Mecocci P, Lovestone S, Newhouse S, Dobson R, Alzheimers Disease Neuroimaging Plasma based markers of [11C] PiB-PET brain amyloid burden. PLoS One. 2012; 7(9):e44260. Epub 2012 Sep 24.
    View PubMed
  61. Couthouis J, Hart MP, Shorter J, DeJesus-Hernandez M, Erion R, Oristano R, Liu AX, Ramos D, Jethava N, Hosangadi D, Epstein J, Chiang A, Diaz Z, Nakaya T, Ibrahim F, Kim HJ, Solski JA, Williams KL, Mojsilovic-Petrovic J, Ingre C, Boylan K, Graff-Radford N A yeast functional screen predicts new candidate ALS disease genes. Proceedings Of The National Academy Of Sciences Of The United States Of. 2011 Dec 27; 108(52):20881-90.
  62. Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, Wszolek ZK, Ferman TJ, Josephs KA, Boylan KB, Rademakers R, Dickson DW. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol. 2011 Dec; 122(6):673-90. Epub 2011 Nov 15.
    View PubMed
  63. Kouri N, Murray ME, Hassan A, Rademakers R, Uitti RJ, Boeve BF, Graff-Radford NR, Wszolek ZK, Litvan I, Josephs KA, Dickson DW. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain. 2011 Nov; 134(Pt 11):3264-75. Epub 2011 Sep 20.
    View PubMed
  64. Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK, Alzheimer's Disease Neuroimaging Initiative. Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology. 2011 Oct 25; 77(17):1619-28. Epub 2011 Oct 12.
    View PubMed
  65. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011 Oct 20; 72(2):245-56. Epub 2011 Sep 21.
    View PubMed
  66. Pao WC, Dickson DW, Crook JE, Finch NA, Rademakers R, Graff-Radford NR. Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis Assoc Disord. 2011 Oct; 25(4):364-8.
    View PubMed
  67. Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ, Alzheimer's Disease Neuroimaging Initiative. Longitudinal change of biomarkers in cognitive decline. Arch Neurol. 2011 Oct; 68(10):1257-66. Epub 2011 Jun 13.
    View PubMed
  68. DeJesus-Hernandez M, Desaro P, Johnston A, Ross OA, Wszolek ZK, Ertekin-Taner N, Graff-Radford NR, Rademakers R, Boylan K. Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS. Neurology. 2011 Sep 13; 77(11):1102-3. Epub 2011 Aug 31.
    View PubMed
  69. Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc. 2011 Sep; 86(9):876-84.
    View PubMed
  70. Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011 Sep; 10(9):785-96. Epub 2011 Jul 27.
    View PubMed
  71. Ferman TJ, Boeve BF, Smith GE, Lin SC, Silber MH, Pedraza O, Wszolek Z, Graff-Radford NR, Uitti R, Van Gerpen J, Pao W, Knopman D, Pankratz VS, Kantarci K, Boot B, Parisi JE, Dugger BN, Fujishiro H, Petersen RC, Dickson DW. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology. 2011 Aug 30; 77(9):875-82. Epub 2011 Aug 17.
    View PubMed
  72. Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M, Adamson J, Li M, Volkening K, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Woodruff BK, Knopman DS, White CL 3rd, Van Gerpen JA, Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet. 2011 Aug 15; 20(16):3207-12. Epub 2011 May 24.
    View PubMed
  73. Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang S, Jack CR Jr, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology. 2011 Jun; 259(3):844-51. Epub 2011 Apr 05.
    View PubMed
  74. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011 May; 43(5):436-41. Epub 2011 Apr 03.
    View PubMed
  75. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011 May; 43(5):429-35. Epub 2011 Apr 03.
    View PubMed
  76. Barrett KM, Brott TG, Brown RD Jr, Carter RE, Geske JR, Graff-Radford NR, McNeil RB, Meschia JF, Mayo Acute Stroke Trial for Enhancing Recovery (MASTER) Study Group. Enhancing recovery after acute ischemic stroke with donepezil as an adjuvant therapy to standard medical care: results of a phase IIA clinical trial. J Stroke Cerebrovasc Dis. 2011 May-Jun; 20(3):177-82. Epub 2011 Feb 03.
    View PubMed
  77. Boeve BF, Molano JR, Ferman TJ, Smith GE, Lin SC, Bieniek K, Haidar W, Tippmann-Peikert M, Knopman DS, Graff-Radford NR, Lucas JA, Petersen RC, Silber MH. Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. Sleep Med. 2011 May; 12(5):445-53. Epub 2011 Feb 23.
    View PubMed
  78. Chen-Plotkin AS, Martinez-Lage M, Sleiman PM, Hu W, Greene R, Wood EM, Bing S, Grossman M, Schellenberg GD, Hatanpaa KJ, Weiner MF, White CL 3rd, Brooks WS, Halliday GM, Kril JJ, Gearing M, Beach TG, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol. 2011 Apr; 68(4):488-97.
    View PubMed
  79. Belbin O, Carrasquillo MM, Crump M, Culley OJ, Hunter TA, Ma L, Bisceglio G, Zou F, Allen M, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG. Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease. Hum Genet. 2011 Mar; 129(3):273-82. Epub 2010 Dec 04.
    View PubMed
  80. Burgess JD, Pedraza O, Graff-Radford NR, Hirpa M, Zou F, Miles R, Nguyen T, Li M, Lucas JA, Ivnik RJ, Crook J, Pankratz VS, Dickson DW, Petersen RC, Younkin SG, Ertekin-Taner N. Association of common KIBRA variants with episodic memory and AD risk. Neurobiol Aging. 2011 Mar; 32(3):557.e1-9. Epub 2010 Dec 24.
    View PubMed
  81. Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, Dejesus-Hernandez M, Crook R, Hunter T, Ghidoni R, Benussi L, Crook J, Finger E, Hantanpaa KJ, Karydas AM, Sengdy P, Gonzalez J, Seeley WW, Johnson N, Beach TG, Mesulam M, Forloni G, Kertesz A, TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology. 2011 Feb 1; 76(5):467-74. Epub 2010 Dec 22.
    View PubMed
  82. Yaffe K, Weston A, Graff-Radford NR, Satterfield S, Simonsick EM, Younkin SG, Younkin LH, Kuller L, Ayonayon HN, Ding J, Harris TB. Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA. 2011 Jan 19; 305(3):261-6.
    View PubMed
  83. Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, Shaw LM, Trojanowski JQ, Potkin SG, Huentelman MJ, Craig DW, DeChairo BM, Aisen PS, Petersen RC, Weiner MW, Saykin AJ, Alzheimer's Disease Neuroimaging Initiative. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology. 2011 Jan 4; 76(1):69-79. Epub 2010 Dec 01.
    View PubMed
  84. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG. Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions. J Alzheimers Dis. 2011; 24(4):751-8.
    View PubMed
  85. Wilson RS, Barral S, Lee JH, Leurgans SE, Foroud TM, Sweet RA, Graff-Radford N, Bird TD, Mayeux R, Bennett DA. Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. J Alzheimers Dis. 2011; 23(2):249-55.
    View PubMed
  86. Graff-Radford NR. Can aerobic exercise protect against dementia? Alzheimers Res Ther. 2011; 3(1):6. Epub 2011 Feb 28.
    View PubMed
  87. Turton JC, Bullock J, Medway C, Shi H, Brown K, Belbin O, Kalsheker N, Carrasquillo MM, Dickson DW, Graff-Radford NR, Petersen RC, Younkin SG, Morgan K. Investigating statistical epistasis in complex disorders. J Alzheimers Dis. 2011; 25(4):635-44.
    View PubMed
  88. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, Passmore P, Morgan K, Alzheimer's Research UK (ARUK) consortium, Younkin SG. Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study. Mol Neurodegener. 2011; 6(1):54. Epub 2011 Jul 28.
    View PubMed
  89. Kocerha J, Kouri N, Baker M, Finch N, DeJesus-Hernandez M, Gonzalez J, Chidamparam K, Josephs KA, Boeve BF, Graff-Radford NR, Crook J, Dickson DW, Rademakers R. Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations. BMC Genomics. 2011; 12:527. Epub 2011 Oct 27.
    View PubMed
  90. O'Bryant SE, Xiao G, Barber R, Huebinger R, Wilhelmsen K, Edwards M, Graff-Radford N, Doody R, Diaz-Arrastia R, Texas Alzheimer's Research & Care Consortium, Alzheimer's Disease Neuroimaging Initiative. A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. PLoS One. 2011; 6(12):e28092. Epub 2011 Dec 7.
    View PubMed
  91. Wolz R, Julkunen V, Koikkalainen J, Niskanen E, Zhang DP, Rueckert D, Soininen H, Lotjonen J, Alzheimer's Disease Neuroimaging Initiative. Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease. PLoS One. 2011; 6(10):e25446. Epub 2011 Oct 13.
    View PubMed
  92. Carrasquillo MM, Nicholson AM, Finch N, Gibbs JR, Baker M, Rutherford NJ, Hunter TA, DeJesus-Hernandez M, Bisceglio GD, Mackenzie IR, Singleton A, Cookson MR, Crook JE, Dillman A, Hernandez D, Petersen RC, Graff-Radford NR, Younkin SG, Rademakers R. Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma. Am J Hum Genet. 2010 Dec 10; 87(6):890-7. Epub 2010 Nov 18.
    View PubMed
  93. Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P, Alzheimer's Disease Genetics Consortium, Cantwell LB, Dombroski BA, Saykin AJ, Reiman EM, Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 2010 Dec; 67(12):1473-84. Epub 2010 Aug 09.
    View PubMed
  94. Vounou M, Nichols TE, Montana G, Alzheimer's Disease Neuroimaging Initiative. Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach. Neuroimage. 2010 Nov 15; 53(3):1147-59. Epub 2010 Jul 17.
    View PubMed
  95. Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Dechairo BM, Potkin SG, Weiner MW, Thompson P, Alzheimer's Disease Neuroimaging Initiative. Voxelwise genome-wide association study (vGWAS). Neuroimage. 2010 Nov 15; 53(3):1160-74. Epub 2010 Feb 17.
    View PubMed
  96. Shen L, Kim S, Risacher SL, Nho K, Swaminathan S, West JD, Foroud T, Pankratz N, Moore JH, Sloan CD, Huentelman MJ, Craig DW, Dechairo BM, Potkin SG, Jack CR Jr, Weiner MW, Saykin AJ, Alzheimer's Disease Neuroimaging Initiative. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage. 2010 Nov 15; 53(3):1051-63. Epub 2010 Jan 25.
    View PubMed
  97. Spreng RN, Rosen HJ, Strother S, Chow TW, Diehl-Schmid J, Freedman M, Graff-Radford NR, Hodges JR, Lipton AM, Mendez MF, Morelli SA, Black SE, Miller BL, Levine B. Occupation attributes relate to location of atrophy in frontotemporal lobar degeneration. Neuropsychologia. 2010 Oct; 48(12):3634-41. Epub 2010 Aug 26.
    View PubMed
  98. Ross OA, Wilhoite GJ, Bacon JA, Soto-Ortolaza A, Kachergus J, Cobb SA, Puschmann A, Vilarino-Guell C, Farrer MJ, Graff-Radford N, Meschia JF, Wszolek ZK. LRRK2 variation and Parkinson's disease in African Americans. Mov Disord. 2010 Sep 15; 25(12):1973-6.
    View PubMed
  99. Pakhomov SV, Smith GE, Chacon D, Feliciano Y, Graff-Radford N, Caselli R, Knopman DS. Computerized analysis of speech and language to identify psycholinguistic correlates of frontotemporal lobar degeneration. Cogn Behav Neurol. 2010 Sep; 23(3):165-77.
    View PubMed
  100. Xu C, Wang Z, Fan M, Liu B, Song M, Zhen X, Jiang T, Alzheimer's Disease Neuroimaging Initiative. Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease. Neuroreport. 2010 Aug 23; 21(12):802-7.
    View PubMed
  101. Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC, Alzheimer's Disease Neuroimaging Initiative investigators. Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment. Neurobiol Aging. 2010 Aug; 31(8):1452-62, 1462.e1-2.
    View PubMed
  102. Pedraza O, Lucas JA, Smith GE, Petersen RC, Graff-Radford NR, Ivnik RJ. Robust and expanded norms for the Dementia Rating Scale. Arch Clin Neuropsychol. 2010 Aug; 25(5):347-58. Epub 2010 Apr 28.
    View PubMed
  103. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG. Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch Neurol. 2010 Aug; 67(8):961-4. Epub 2010 Jun 14.
    View PubMed
  104. Rademakers R, Stewart H, Dejesus-Hernandez M, Krieger C, Graff-Radford N, Fabros M, Briemberg H, Cashman N, Eisen A, Mackenzie IR. Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis. Muscle Nerve. 2010 Aug; 42(2):170-6.
    View PubMed
  105. Meschia JF, McNeil RB, Barrett KM, Brott TG, Graff-Radford NR, Brown RD Jr. Mayo Acute Stroke Trial for Enhancing Recovery (MASTER) protocol. J Stroke Cerebrovasc Dis. 2010 Jul-Aug; 19(4):299-310.
    View PubMed
  106. Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, Seelaar H, Van Swieten JC, Brown JM, Johannsen P, Nielsen JE, Holm IE, FReJA Consortium, Dickson DW, Rademakers R, Graff-Radford NR, Parisi JE, Petersen RC, Hatanpaa KJ, White CL 3rd, FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010 Jul; 120(1):33-41. Epub 2010 May 20.
    View PubMed
  107. Wilson RS, Leurgans SE, Foroud TM, Sweet RA, Graff-Radford N, Mayeux R, Bennett DA, National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group. Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Arch Neurol. 2010 Jul; 67(7):855-61.
    View PubMed
  108. Walhovd KB, Fjell AM, Dale AM, McEvoy LK, Brewer J, Karow DS, Salmon DP, Fennema-Notestine C, Alzheimer's Disease Neuroimaging Initiative. Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol Aging. 2010 Jul; 31(7):1107-21. Epub 2008 Oct 05.
    View PubMed
  109. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC, Harold D, Schrijvers EM, Ramirez-Lorca R, Debette S, Longstreth WT Jr, Janssens AC, Pankratz VS, Dartigues JF, Hollingworth P, Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010 May 12; 303(18):1832-40.
    View PubMed
  110. Keihaninejad S, Heckemann RA, Fagiolo G, Symms MR, Hajnal JV, Hammers A, Alzheimer's Disease Neuroimaging Initiative. A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T). Neuroimage. 2010 May 1; 50(4):1427-37. Epub 2010 Jan 28.
    View PubMed
  111. DeJesus-Hernandez M, Kocerha J, Finch N, Crook R, Baker M, Desaro P, Johnston A, Rutherford N, Wojtas A, Kennelly K, Wszolek ZK, Graff-Radford N, Boylan K, Rademakers R. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum Mutat. 2010 May; 31(5):E1377-89.
    View PubMed
  112. Sweet RA, Bennett DA, Graff-Radford NR, Mayeux R, National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group. Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Brain. 2010 Apr; 133(Pt 4):1155-62. Epub 2010 Feb 10.
    View PubMed
  113. Pakhomov SV, Smith GE, Marino S, Birnbaum A, Graff-Radford N, Caselli R, Boeve B, Knopman DS. A computerized technique to assess language use patterns in patients with frontotemporal dementia. J Neurolinguistics. 2010 Mar 1; 23(2):127-44.
    View PubMed
  114. Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P, van Swieten JC, Murrell JR, Ghetti B, Spina S, Grafman Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010 Mar; 42(3):234-9. Epub 2010 Feb 14.
    View PubMed
  115. Hu B, Ross L, Neuhaus J, Knopman D, Kramer J, Boeve B, Caselli RJ, Graff-Radford N, Mendez MF, Miller BL, Boxer AL. Off-label medication use in frontotemporal dementia. American Journal Of Alzheimers Disease And Other Dementias. 2010 Mar; 25(2):128-33.
  116. Zou F, Carrasquillo MM, Pankratz VS, Belbin O, Morgan K, Allen M, Wilcox SL, Ma L, Walker LP, Kouri N, Burgess JD, Younkin LH, Younkin SG, Younkin CS, Bisceglio GD, Crook JE, Dickson DW, Petersen RC, Graff-Radford N, Younkin SG, Ertekin-Taner N. Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease. Neurology. 2010 Feb 9; 74(6):480-6.
    View PubMed
  117. Molano J, Boeve B, Ferman T, Smith G, Parisi J, Dickson D, Knopman D, Graff-Radford N, Geda Y, Lucas J, Kantarci K, Shiung M, Jack C, Silber M, Pankratz VS, Petersen R. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain. 2010 Feb; 133(Pt 2):540-56. Epub 2009 Nov 04.
    View PubMed
  118. Carrasquillo MM, Belbin O, Zou F, Allen M, Ertekin-Taner N, Ansari M, Wilcox SL, Kashino MR, Ma L, Younkin LH, Younkin SG, Younkin CS, Dincman TA, Howard ME, Howell CC, Stanton CM, Watson CM, Crump M, Vitart V, Hayward C, Hastie ND, Rudan I, Campbell H, Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease. PLoS One. 2010; 5(1):e8764. Epub 2010 Jan 19.
    View PubMed
  119. Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, Younkin CS, Younkin LH, Bisceglio GD, Ertekin-Taner N, Crook JE, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG. Genetic variation in PCDH11X is associated with susceptibility to late onset alzheimer's disease. Hirosaki Medical Journal. 2010; 61(Suppl):S125-34.
  120. Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA, Zavitz KH, Tarenflurbil Phase 3 Study Group. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA. 2009 Dec 16; 302(23):2557-64.
    View PubMed
  121. Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Dale AM, Alzheimer's Disease Neuroimaging Initiative. Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A. 2009 Dec 8; 106(49):20954-9.
    View PubMed
  122. Pedraza O, Dotson VM, Willis FB, Graff-Radford NR, Lucas JA. Internal Consistency and Test-Retest Stability of the Geriatric Depression Scale-Short Form in African American Older Adults. J Psychopathol Behav Assess. 2009 Dec 1; 31(4):412-416.
    View PubMed
  123. Pedraza O, Graff-Radford NR, Smith GE, Ivnik RJ, Willis FB, Petersen RC, Lucas JA. Differential item functioning of the Boston Naming Test in cognitively normal African American and Caucasian older adults. J Int Neuropsychol Soc. 2009 Sep; 15(5):758-68. Epub 2009 Jul 02.
    View PubMed
  124. Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL, Alzheimer's Disease Cooperative Study Group. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology. 2009 Jun 16; 72(24):2115-21.
    View PubMed
  125. Vilarino-Guell C, Wider C, Soto-Ortolaza AI, Cobb SA, Kachergus JM, Keeling BH, Dachsel JC, Hulihan MM, Dickson DW, Wszolek ZK, Uitti RJ, Graff-Radford NR, Boeve BF, Josephs KA, Miller B, Boylan KB, Gwinn K, Adler CH, Aasly JO, Hentati F, Destee A, Characterization of DCTN1 genetic variability in neurodegeneration. Neurology. 2009 Jun 9; 72(23):2024-8.
    View PubMed
  126. Knopman DS, Jack CR Jr, Kramer JH, Boeve BF, Caselli RJ, Graff-Radford NR, Mendez MF, Miller BL, Mercaldo ND. Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology. 2009 May 26; 72(21):1843-9.
    View PubMed
  127. Kelley BJ, Haidar W, Boeve BF, Baker M, Graff-Radford NR, Krefft T, Frank AR, Jack CR Jr, Shiung M, Knopman DS, Josephs KA, Parashos SA, Rademakers R, Hutton M, Pickering-Brown S, Adamson J, Kuntz KM, Dickson DW, Parisi JE, Smith GE, Ivnik RJ, Petersen Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging. 2009 May; 30(5):739-51. Epub 2007 Oct 18.
    View PubMed
  128. Rollinson S, Rizzu P, Sikkink S, Baker M, Halliwell N, Snowden J, Traynor BJ, Ruano D, Cairns N, Rohrer JD, Mead S, Collinge J, Rossor M, Akay E, Guerreiro R, Rademakers R, Morrison KE, Pastor P, Alonso E, Martinez-Lage P, Graff-Radford N, Neary D, Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration. Neurobiol Aging. 2009 Apr; 30(4):656-65. Epub 2009 Feb 12.
    View PubMed
  129. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Cummings J, DeCarli C, Foster NL, Galasko D, Peskind E, Dietrich W, Beekly DL, Kukull WA, Morris JC. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord. 2009 Apr-Jun; 23(2):91-101.
    View PubMed
  130. Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, Bisceglio G, Rovelet-Lecrux A, Boeve B, Petersen RC, Dickson DW, Younkin SG, Deramecourt V, Crook J, Graff-Radford NR, Rademakers R. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain. 2009 Mar; 132(Pt 3):583-91. Epub 2009 Jan 21.
    View PubMed
  131. Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, Younkin SG, Younkin CS, Younkin LH, Bisceglio GD, Ertekin-Taner N, Crook JE, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat Genet. 2009 Feb; 41(2):192-8. Epub 2009 Jan 11.
    View PubMed
  132. Rabins PV, Graff-Radford N, Small GW, Yaari R. New developments in the treatment of Alzheimer's disease the planning teleconference series. J Clin Psychiatry. 2009; 70(2):281-90.
  133. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ, Josephs KA, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Caselli RJ, Wszolek ZK, Uitti RJ, Feldman H, Hutton ML, Mackenzie IR, Graff-Radford NR, Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet. 2008 Dec 1; 17(23):3631-42. Epub 2008 Aug 21.
    View PubMed
  134. Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R, National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group. Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. Arch Neurol. 2008 Nov; 65(11):1518-26.
    View PubMed
  135. Knopman DS, Kramer JH, Boeve BF, Caselli RJ, Graff-Radford NR, Mendez MF, Miller BL, Mercaldo N. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain. 2008 Nov; 131(Pt 11):2957-68. Epub 2008 Oct 01.
    View PubMed
  136. Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ, Alzheimer Disease Cooperative Study. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA. 2008 Oct 15; 300(15):1774-83.
    View PubMed
  137. Jack CR Jr, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Sencakova D, Doody RS, Thal LJ, Members of the Alzheimer's Disease Cooperative Study (ADCS). Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging. 2008 Sep; 29(9):1285-95. Epub 2007 Apr 23.
    View PubMed
  138. Josephs KA, Lin WL, Ahmed Z, Stroh DA, Graff-Radford NR, Dickson DW. Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions. Acta Neuropathol. 2008 Aug; 116(2):159-67. Epub 2008 Jun 14.
    View PubMed
  139. Rudzinski LA, Fletcher RM, Dickson DW, Crook R, Hutton ML, Adamson J, Graff-Radford NR. Early onset familial Alzheimer Disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1. Alzheimer Dis Assoc Disord. 2008 Jul-Sep; 22(3):299-307.
    View PubMed
  140. O'Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, Lucas JA. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol. 2008 Jul; 65(7):963-7.
    View PubMed
  141. Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol. 2008 Jul; 67(7):649-56.
    View PubMed
  142. Kim J, Miller VM, Levites Y, West KJ, Zwizinski CW, Moore BD, Troendle FJ, Bann M, Verbeeck C, Price RW, Smithson L, Sonoda L, Wagg K, Rangachari V, Zou F, Younkin SG, Graff-Radford N, Dickson D, Rosenberry T, Golde TE. BRI2 (ITM2b) inhibits Abeta deposition in vivo. J Neurosci. 2008 Jun 4; 28(23):6030-6.
    View PubMed
  143. Zou F, Gopalraj RK, Lok J, Zhu H, Ling IF, Simpson JF, Tucker HM, Kelly JF, Younkin SG, Dickson DW, Petersen RC, Graff-Radford NR, Bennett DA, Crook JE, Younkin SG, Estus S. Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. Hum Mol Genet. 2008 Apr 1; 17(7):929-35. Epub 2007 Dec 08.
    View PubMed
  144. Ertekin-Taner N, Younkin LH, Yager DM, Parfitt F, Baker MC, Asthana S, Hutton ML, Younkin SG, Graff-Radford NR. Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families. Neurology. 2008 Feb 19; 70(8):596-606. Epub 2007 Oct 03.
    View PubMed
  145. Josephs KA, Whitwell JL, Duffy JR, Vanvoorst WA, Strand EA, Hu WT, Boeve BF, Graff-Radford NR, Parisi JE, Knopman DS, Dickson DW, Jack CR Jr, Petersen RC. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology. 2008 Jan 1; 70(1):25-34.
    View PubMed
  146. Sano M, Jacobs D, Andrews H, Bell K, Graff-Radford N, Lucas J, Rabins P, Bolla K, Tsai WY, Cross P, Andrews K, Costa R, Xiaodong Luo. A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics. Clin Trials. 2008; 5(5):523-33.
    View PubMed
  147. Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, Sreedharan J, Vance C, Sorenson E, Lippa C, Bigio EH, Geschwind DH, Knopman DS, Mitsumoto H, Petersen RC, Cashman NR, Hutton M, Shaw CE, Boylan KB, Boeve Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008; 4(9):e1000193. Epub 2008 Sep 19.
    View PubMed
  148. Geda YE, Boeve BF, Negash S, Graff-Radford NR, Knopman DS, Parisi JE, Dickson DW, Petersen RC. Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. J Neuropsychiatry Clin Neurosci. 2007 Winter; 19(1):77-80.
    View PubMed
  149. Knopman DS, Boeve BS, Caselli RJ, Graff-Radford NR, Kramer JH, Mendez MF, Miller BL. Longitudinal tracking of FTLD: toward developing clinical trial methodology. Alzheimer Dis Assoc Disord. 2007 Oct-Dec; 21(4):S58-63.
    View PubMed
  150. Galasko DR, Graff-Radford N, May S, Hendrix S, Cottrell BA, Sagi SA, Mather G, Laughlin M, Zavitz KH, Swabb E, Golde TE, Murphy MP, Koo EH. Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals. Alzheimer Dis Assoc Disord. 2007 Oct-Dec; 21(4):292-9.
    View PubMed
  151. Rademakers R, Baker M, Gass J, Adamson J, Huey ED, Momeni P, Spina S, Coppola G, Karydas AM, Stewart H, Johnson N, Hsiung GY, Kelley B, Kuntz K, Steinbart E, Wood EM, Yu CE, Josephs K, Sorenson E, Womack KB, Weintraub S, Pickering-Brown SM, Schofield PR, Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Lancet Neurol. 2007 Oct; 6(10):857-68.
    View PubMed
  152. Graff-Radford NR. Normal pressure hydrocephalus. Neurol Clin. 2007 Aug; 25(3):809-32, vii-viii.
    View PubMed
  153. Graff-Radford NR. Preface. Neurol Clin. 2007 Aug; 25(3):xi-xii.
  154. Smith GE, Pankratz VS, Negash S, Machulda MM, Petersen RC, Boeve BF, Knopman DS, Lucas JA, Ferman TJ, Graff-Radford N, Ivnik RJ. A plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms? Neurology. 2007 Jul 10; 69(2):133-9.
    View PubMed
  155. Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P, Elder J, Chio A, Restagno G, Robberecht W, Dahlberg C, Mukherjee O, Goate A, Graff-Radford N, Caselli RJ, Hutton M, Gass J, Cannon A, Rademakers R, Singleton AB, Hardiman O, Rothstein J Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry. 2007 Jul; 78(7):754-6 Epub 2007 Mar 19.
    View PubMed
  156. Pedraza O, Smith GE, Ivnik RJ, Willis FB, Ferman TJ, Petersen RC, Graff-Radford NR, Lucas JA. Reliable change on the Dementia Rating Scale. J Int Neuropsychol Soc. 2007 Jul; 13(4):716-20. Epub 2007 May 18.
    View PubMed
  157. Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol. 2007 May; 61(5):435-45.
    View PubMed
  158. Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet. 2007 Apr; 80(4):769-78. Epub 2007 Mar 08.
    View PubMed
  159. O'Bryant SE, Lucas JA, Willis FB, Smith GE, Graff-Radford NR, Ivnik RJ. Discrepancies between self-reported years of education and estimated reading level among elderly community-dwelling African-Americans: Analysis of the MOAANS data. Arch Clin Neuropsychol. 2007 Mar; 22(3):327-32. Epub 2007 Mar 02.
    View PubMed
  160. Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol. 2007 Mar; 64(3):354-62.
    View PubMed
  161. Hawkins DB, Graff-Radford NR. The ability to pun may be retained in Alzheimer disease. Neurocase. 2007 Feb; 13(1):50-4.
    View PubMed
  162. Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, Petersen RC, Davies P, Duara R, Graff-Radford NR, Uitti RJ, Rademakers R, Adamson J, Baker M, Hutton ML, Dickson DW. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol. 2007 Feb; 66(2):142-51.
    View PubMed
  163. Graff-Radford NR, Woodruff BK. Frontotemporal dementia. Semin Neurol. 2007 Feb; 27(1):48-57.
    View PubMed
  164. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H, Chen F, Shibata N, Lunetta KL, Pardossi-Piquard R, Bohm C, Wakutani Y, Cupples LA, Cuenco KT, Green RC, Pinessi L, Rainero I, Sorbi S, Bruni A, Duara R, The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet. 2007 Feb; 39(2):168-77. Epub 2007 Jan 14.
    View PubMed
  165. Mesulam M, Johnson N, Krefft TA, Gass JM, Cannon AD, Adamson JL, Bigio EH, Weintraub S, Dickson DW, Hutton ML, Graff-Radford NR. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol. 2007 Jan; 64(1):43-7.
    View PubMed
  166. Graff-Radford NR. Normal pressure hydrocephalus. CONTINUUM Lifelong Learn. Neurol. 2007; 13(2):144-64.
  167. Ferman TJ, Smith GE, Boeve BF, Graff-Radford NR, Lucas JA, Knopman DS, Petersen RC, Ivnik RJ, Wszolek Z, Uitti R, Dickson DW. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease. Clin Neuropsychol. 2006 Dec; 20(4):623-36.
    View PubMed
  168. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, Wszolek Z, Gonzalez J, Beach TG, Bigio E, Johnson N, Weintraub S, Mesulam M, White Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006 Oct 15; 15(20):2988-3001. Epub 2006 Sep 01.
    View PubMed
  169. Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4):210-6.
    View PubMed
  170. Woodruff BK, Graff-Radford NR, Ferman TJ, Dickson DW, DeLucia MW, Crook JE, Arvanitakis Z, Brassler S, Waters C, Barker W, Duara R. Family history of dementia is a risk factor for Lewy body disease. Neurology. 2006 Jun 27; 66(12):1949-50.
    View PubMed
  171. Graff-Radford NR, Ferman TJ, Lucas JA, Johnson HK, Parfitt FC, Heckman MG, Todd M, Sadowsky C, Epstein DE, Crook JE. A cost effective method of identifying and recruiting persons over 80 free of dementia or mild cognitive impairment. Alzheimer Dis Assoc Disord. 2006 Apr-Jun; 20(2):101-4.
    View PubMed
  172. Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, DeCarli C, Jagust WJ, Clark CM, Mendez MF, Tang-Wai DF, Graff-Radford NR, Galasko D. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005 Aug 9; 65(3):397-403.
    View PubMed
  173. Short RA, Broderick DF, Patton A, Arvanitakis Z, Graff-Radford NR. Different patterns of magnetic resonance imaging atrophy for frontotemporal lobar degeneration syndromes. Arch Neurol. 2005 Jul; 62(7):1106-10.
    View PubMed
  174. Rilling LM, Lucas JA, Ivnik RJ, Smith GE, Willis FB, Ferman TJ, Petersen RC, Graff-Radford NR. Mayo's Older African American Normative Studies: norms for the Mattis Dementia Rating Scale. Clin Neuropsychol. 2005 Jun; 19(2):229-42.
    View PubMed
  175. Lucas JA, Ivnik RJ, Willis FB, Ferman TJ, Smith GE, Parfitt FC, Petersen RC, Graff-Radford NR. Mayo's Older African Americans Normative Studies: normative data for commonly used clinical neuropsychological measures. Clin Neuropsychol. 2005 Jun; 19(2):162-83.
    View PubMed
  176. Lucas JA, Ivnik RJ, Smith GE, Ferman TJ, Willis FB, Petersen RC, Graff-Radford NR. A brief report on WAIS-R normative data collection in Mayo's Older African Americans Normative Studies. Clin Neuropsychol. 2005 Jun; 19(2):184-8.
    View PubMed
  177. Lucas JA, Ivnik RJ, Smith GE, Ferman TJ, Willis FB, Petersen RC, Graff-Radford NR. Mayo's Older African Americans Normative Studies: WMS-R norms for African American elders. Clin Neuropsychol. 2005 Jun; 19(2):189-213.
    View PubMed
  178. Ferman TJ, Lucas JA, Ivnik RJ, Smith GE, Willis FB, Petersen RC, Graff-Radford NR. Mayo's Older African American Normative Studies: Auditory Verbal Learning Test norms for African American elders. Clin Neuropsychol. 2005 Jun; 19(2):214-28.
    View PubMed
  179. Lucas JA, Ivnik RJ, Smith GE, Ferman TJ, Willis FB, Petersen RC, Graff-Radford NR. Mayo's Older African Americans Normative Studies: norms for Boston Naming Test, Controlled Oral Word Association, Category Fluency, Animal Naming, Token Test, WRAT-3 Reading, Trail Making Test, Stroop Test, and Judgment of Line Orientation. Clin Neuropsychol. 2005 Jun; 19(2):243-69.
    View PubMed
  180. Pedraza O, Lucas JA, Smith GE, Willis FB, Graff-Radford NR, Ferman TJ, Petersen RC, Bowers D, Ivnik RJ. Mayo's older African American normative studies: confirmatory factor analysis of a core battery. J Int Neuropsychol Soc. 2005 Mar; 11(2):184-91.
    View PubMed
  181. Ertekin-Taner N, Ronald J, Feuk L, Prince J, Tucker M, Younkin L, Hella M, Jain S, Hackett A, Scanlin L, Kelly J, Kihiko-Ehman M, Neltner M, Hersh L, Kindy M, Markesbery W, Hutton M, de Andrade M, Petersen RC, Graff-Radford N, Estus S, Brookes AJ, Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Hum Mol Genet. 2005 Feb 1; 14(3):447-60. Epub 2004 Dec 22.
    View PubMed
  182. Boughey JGF, Graff-Radford NR. Gaining insights into Alzheimer's Disease. NortheastFlorida Medicine. 2005; 56(5):10-7.
  183. Tang-Wai DF, Graff-Radford NR, Boeve BF, Dickson DW, Parisi JE, Crook R, Caselli RJ, Knopman DS, Petersen RC. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 2004 Oct 12; 63(7):1168-74.
    View PubMed
  184. Ertekin-Taner N, Allen M, Fadale D, Scanlin L, Younkin L, Petersen RC, Graff-Radford N, Younkin SG. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease. Hum Mutat. 2004 Apr; 23(4):334-42.
    View PubMed
  185. Ferman TJ, Smith GE, Boeve BF, Ivnik RJ, Petersen RC, Knopman D, Graff-Radford N, Parisi J, Dickson DW. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004 Jan 27; 62(2):181-7.
    View PubMed
  186. Krefft TA, Graff-Radford NR, Lucas JA, Mortimer JA. Normal pressure hydrocephalus and large head size. Alzheimer Disease & Associated Disorders. 2004 Jan-Mar; 18(1):35-7.
    View PubMed
  187. Ertekin-Taner N, Ronald J, Asahara H, Younkin L, Hella M, Jain S, Gnida E, Younkin S, Fadale D, Ohyagi Y, Singleton A, Scanlin L, de Andrade M, Petersen R, Graff-Radford N, Hutton M, Younkin S. Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Hum Mol Genet. 2003 Dec 1; 12(23):3133-43. Epub 2003 Oct 14.
    View PubMed
  188. Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Neuropathol Appl Neurobiol. 2003 Oct; 29(5):503-10.
    View PubMed
  189. Finton MJ, Lucas JA, Rippeth JD, Bohac DL, Smith GE, Ivnik RJ, Petersen RC, Graff-Radford NR. Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease. J Int Neuropsychol Soc. 2003 Jul; 9(5):751-9.
    View PubMed
  190. Krefft TA, Graff-Radford NR, Dickson DW, Baker M, Castellani RJ. Familial primary progressive aphasia. Alzheimer Disease & Associated Disorders. 2003 Apr-Jun; 17(2):106-12.
    View PubMed
  191. Willis F, Graff-Radford N, Pinto M, Lawson L, Adamson J, Epstein D, Parfitt F, Hutton M, O'Brien PC. Apolipoprotein epsilon4 allele frequency in young Africans of Ugandan descent versus African Americans. J Natl Med Assoc. 2003 Jan; 95(1):71-6.
    View PubMed
  192. Bird T, Knopman D, VanSwieten J, Rosso S, Feldman H, Tanabe H, Graff-Raford N, Geschwind D, Verpillat P, Hutton M. Epidemiology and genetics of frontotemporal dementia/Pick's disease. Ann Neurol. 2003; 54 Suppl 5:S29-31.
    View PubMed
  193. Ferman TJ, Boeve BF, Smith GE, Silber MH, Lucas JA, Graff-Radford NR, Dickson DW, Parisi JE, Petersen RC, Ivnik RJ. Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations. J Int Neuropsychol Soc. 2002 Nov; 8(7):907-14.
    View PubMed
  194. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, Waters C, Jimison P, Shepherd E, Sevush S, Graff-Radford N, Newland D, Todd M, Miller B, Gold M, Heilman K, Doty L, Goodman I, Robinson B, Pearl G, Dickson D, Duara R. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida Brain Bank. Alzheimer Disease & Associated Disorders. 2002 Oct-Dec; 16(4):203-12.
    View PubMed
  195. Arvanitakis Z, Lucas JA, Younkin LH, Younkin SG, Graff-Radford NR. Serum creatinine levels correlate with plasma amyloid beta protein. Alzheimer Disease & Associated Disorders. 2002 Jul-Sep; 16(3):187-90.
    View PubMed
  196. Graff-Radford NR, Green RC, Go RCP, Hutton ML, Edeki T, Bachman D, Adamson JL, Griffith P, Willis FB, Williams M, Hipps Y, Haines JL, Cupples LA, Farrer LA. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects. Arch Neurol. 2002 Apr; 59(4):594-600.
    View PubMed
  197. Short RA, Graff-Radford NR, Adamson J, Baker M, Hutton M. Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch Neurol. 2002 Apr; 59(4):611-5.
    View PubMed
  198. Green RC, Cupples LA, Go R, Benke KS, Edeki T, Griffith PA, Williams M, Hipps Y, Graff-Radford N, Bachman D, Farrer LA. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA: Journal of the American Medical Association. 2002 Jan 16; 287(3):329-36.
    View PubMed
  199. Caselli RJ, Hentz JG, Osborne D, Graff-Radford NR, Barbieri CJ, Alexander GE, Hall GR, Reiman EM, Hardy J, Saunders AM. Apolipoprotein E and intellectual achievement. J Am Geriatr Soc. 2002 Jan; 50(1):49-54.
    View PubMed
  200. Chukwudelunzu FE, Meschia JF, Graff-Radford NR, Lucas JA. Extensive metabolic and neuropsychological abnormalities associated with discrete infarction of the genu of the internal capsule. J Neurol Neurosurg Psychiatry. 2001 Nov; 71(5):658-62.
    View PubMed
  201. Sencakova D, Graff-Radford NR, Willis FB, Lucas JA, Parfitt F, Cha RH, O'Brien PC, Petersen RC, Jack CR Jr. Hippocampal atrophy correlates with clinical features of Alzheimer disease in African Americans. Arch Neurol. 2001 Oct; 58(10):1593-7.
    View PubMed
  202. Short RA, Bowen RL, O'Brien PC, Graff-Radford NR. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc. 2001 Sep; 76(9):906-9.
    View PubMed
  203. Caselli RJ, Osborne D, Reiman EM, Hentz JG, Barbieri CJ, Saunders AM, Hardy J, Graff-Radford NR, Hall GR, Alexander GE. Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study. J Neurol Sci. 2001 Aug 15; 189(1-2):93-8.
    View PubMed
  204. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Adamson J, Schaid DJ, Blangero J, Hutton M, Younkin SG. Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees. Genet Epidemiol. 2001 Jul; 21(1):19-30.
    View PubMed
  205. Bokde AL, Pietrini P, Ibanez V, Furey ML, Alexander GE, Graff-Radford NR, Rapoport SI, Schapiro MB, Horwitz B. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease. Arch Neurol. 2001 Mar; 58(3):480-6.
    View PubMed
  206. Graff-Radford NR. Commentary on, A Cognitive Neuroscience Perspective of Confabulations. Neuro-Psychoanalysis. 2001; 2:32-3.
  207. Short RA, Graff-Radford NR. Localization of hemiachromatopsia. Neurocase. 2001; 7(4):331-7.
    View PubMed
  208. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin SG. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science. 2000 Dec 22; 290(5500):2303-4.
    View PubMed
  209. Brazis PW, Lee AG, Graff-Radford N, Desai NP, Eggenberger ER. Homonymous visual field defects in patients without corresponding structural lesions on neuroimaging. J Neuroophthalmol. 2000 Jun; 20(2):92-6.
    View PubMed
  210. Baker M, Graff-Radford D, Wavrant DeVrieze F, Graff-Radford N, Petersen RC, Kokmen E, Boeve B, Myllykangas L, Polvikoski T, Sulkava R, Verkoniemmi A, Tienari P, Haltia M, Hardy J, Hutton M, Perez-Tur J. No association between TAU haplotype and Alzheimer's disease in population or clinic based series or in familial disease. Neurosci Lett. 2000 May 12; 285(2):147-9.
    View PubMed
  211. Graff-Radford N. Alzheimer's disease. Jacksonville Medicine. 2000; 51:57-62.
  212. Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, Caselli RJ, Dickson DW, Kokmen E, Petersen RC. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology. 1999 Sep 11; 53(4):795-800.
    View PubMed
  213. Caselli RJ, Graff-Radford NR, Reiman EM, Weaver A, Osborne D, Lucas J, Uecker A, Thibodeau SN. Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes. Neurology. 1999 Jul 13; 53(1):201-7.
    View PubMed
  214. Brazis PW, Graff-Radford NR, Newman NJ, Lee AG. Ishihara color plates as a test for simultanagnosia. Am J Ophthalmol. 1998 Dec; 126(6):850-1.
    View PubMed
  215. Lucas JA, Ivnik RJ, Smith GE, Bohac DL, Tangalos EG, Kokmen E, Graff-Radford NR, Petersen RC. Normative data for the Mattis Dementia Rating Scale. J Clin Exp Neuropsychol. 1998 Aug; 20(4):536-47.
    View PubMed
  216. Lucas JA, Ivnik RJ, Smith GE, Bohac DL, Tangalos EG, Graff-Radford NR, Petersen RC. Mayo's older Americans normative studies: category fluency norms. J Clin Exp Neuropsychol. 1998 Apr; 20(2):194-200.
    View PubMed
  217. Finton MJ, Lucas JA, Graff-Radford NR, Uitti RJ. Analysis of visuospatial errors in patients with Alzheimer's disease or Parkinson's disease. J Clin Exp Neuropsychol. 1998 Apr; 20(2):186-93.
    View PubMed
  218. Eckman CB, Mehta ND, Crook R, Perez-tur J, Prihar G, Pfeiffer E, Graff-Radford N, Hinder P, Yager D, Zenk B, Refolo LM, Prada CM, Younkin SG, Hutton M, Hardy J. A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43). Hum Mol Genet. 1997 Nov; 6(12):2087-9.
    View PubMed
  219. Uitti RJ, Wharen RE Jr, Turk MF, Lucas JA, Finton MJ, Graff-Radford NR, Boylan KB, Goerss SJ, Kall BA, Adler CH, Caviness JN, Atkinson EJ. Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Neurology. 1997 Oct; 49(4):1072-7.
    View PubMed
  220. Graff-Radford NR, Lin SC, Brazis PW, Bolling JP, Liesegang TJ, Lucas JA, Uitti RJ, O'Brien PC. Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease. Mayo Clin Proc. 1997 Jun; 72(6):495-504.
    View PubMed
  221. Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. Am J Psychiatry. 1996 Oct; 153(10):1261-8.
    View PubMed
  222. Furey-Kurkjian ML, Pietrini P, Graff-Radford NR, Alexander GE, Freo U, Szczepanik J, Schapiro MB, Rapoport SI. The visual variant of Alzheimer's disease: distinctive neuropsychological features. Neuropsychology. 1996; 10:294-300.
  223. Graff-Radford NR, Russell JW, Rezai K. Frontal degenerative dementia and neuroimaging. Adv Neurol. 1995; 66:37-47, discussion 47-50.
    View PubMed
  224. Kuzniecky R, Andermann F, Guerrini R, CBPS Multicenter Collaborative Study. The epileptic spectrum in the congenital bilateral perisylvian syndrome. Neurology. 1994 Mar; 44(3 Pt 1):379-85.
    View PubMed
  225. Wood JA, Wood PL, Ryan R, Graff-Radford NR, Pilapil C, Robitaille Y, Quirion R. Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res. 1993 Dec 3; 629(2):245-52.
    View PubMed
  226. Graff-Radford NR, Bolling JP, Earnest F 4th, Shuster EA, Caselli RJ, Brazis PW. Simultanagnosia as the initial sign of degenerative dementia. Mayo Clin Proc. 1993 Oct; 68(10):955-64.
    View PubMed
  227. Kuzniecky R, Andermann F, Guerrini R. Congenital bilateral perisylvian syndrome: study of 31 patients. The CBPS Multicenter Collaborative Study. Lancet. 1993 Mar 6; 341(8845):608-12.
    View PubMed
  228. Caselli RJ, Windebank AJ, Petersen RC, Komori T, Parisi JE, Okazaki H, Kokmen E, Iverson R, Dinapoli RP, Graff-Radford NR, et al. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol. 1993 Feb; 33(2):200-7.
    View PubMed
  229. Graff-Radford NR, Godersky JC. Symptomatic or normal pressure hydrocephalus in the elderly. Jacksonville Medicine. 1993; 44:578-82.
  230. Malamut BL, Graff-Radford N, Chawluk J, Grossman RI, Gur RC. Memory in a case of bilateral thalamic infarction. Neurology. 1992 Jan; 42(1):163-9.
    View PubMed
  231. Bruno A, Adams Jr HP, Biller J, Graff-Radford NR, Grimsman KJ. Carotid artery findings associated with infarcts in different vascular territories. J Stroke and Cerebrovascular Disease. 1991; 1:99-102.
  232. Graff-Radford NR. Alzheimer's disease: an update. Jacksonville Medicine. The Journal of the Duval Medical Society. 1991; 42:144-6.
  233. Caselli RJ, Graff-Radford NR, Rezai K. Thalamocortical diaschisis: a single photon emission tomography (SPET) study of cortical perfusion changes following focal thalamic infarctions. Neuropsychiatry Neuropsychol Behav Neurol. 1991; 4:193-214.
  234. Graff-Radford NR. A report on two projects prior to the creation of the Iowa Registry. Aging-Clinical & Experimental Research. 1990 Sep; 2(3):305-8.
    View PubMed
  235. Graff-Radford NR, Damasio AR, Hyman BT, Hart MN, Tranel D, Damasio H, Van Hoesen GW, Rezai K. Progressive aphasia in a patient with Pick's disease: a neuropsychological, radiologic, and anatomic study. Neurology. 1990 Apr; 40(4):620-6.
    View PubMed
  236. Graff-Radford NR, Tranel D, Van Hoesen GW, Brandt JP. Diencephalic amnesia. Brain. 1990 Feb; 113 ( Pt 1):1-25.
    View PubMed
  237. Graff-Radford NR, Godersky JC. Symptomatic congenital hydrocephalus in the elderly simulating normal pressure hydrocephalus. Neurology. 1989 Dec; 39(12):1596-600.
    View PubMed
  238. Graff-Radford NR, Godersky JC, Jones MP. Variables predicting surgical outcome in symptomatic hydrocephalus in the elderly. Neurology. 1989 Dec; 39(12):1601-4.
    View PubMed
  239. Graff-Radford NR, Torner J, Adams HP Jr, Kassell NF. Factors associated with hydrocephalus after subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Arch Neurol. 1989 Jul; 46(7):744-52.
    View PubMed
  240. Bruno A, Graff-Radford NR, Biller J, Adams HP Jr. Anterior choroidal artery territory infarction: a small vessel disease. Stroke. 1989 May; 20(5):616-9.
    View PubMed


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.